Fes-Deficient Macrophages Prime CD8+ T Cells to Stimulate Antitumor Immunity and Improve Immunotherapy Efficacy.

Saved in:
Bibliographic Details
Title: Fes-Deficient Macrophages Prime CD8+ T Cells to Stimulate Antitumor Immunity and Improve Immunotherapy Efficacy.
Authors: Laight BJ; Division of Cancer Biology and Genetics, Sinclair Cancer Research Institute, Kingston, Canada.; Department of Pathology and Molecular Medicine, Queen's University, Kingston, Canada., Harper D; Division of Cancer Biology and Genetics, Sinclair Cancer Research Institute, Kingston, Canada.; Department of Pathology and Molecular Medicine, Queen's University, Kingston, Canada., Dmytryk N; Division of Cancer Biology and Genetics, Sinclair Cancer Research Institute, Kingston, Canada.; Department of Pathology and Molecular Medicine, Queen's University, Kingston, Canada., Zhang CS; Division of Cancer Biology and Genetics, Sinclair Cancer Research Institute, Kingston, Canada.; Department of Pathology and Molecular Medicine, Queen's University, Kingston, Canada., Shi C; Division of Cancer Biology and Genetics, Sinclair Cancer Research Institute, Kingston, Canada., Garven A; Division of Cancer Biology and Genetics, Sinclair Cancer Research Institute, Kingston, Canada.; Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Canada., Nauman RW; Division of Cancer Biology and Genetics, Sinclair Cancer Research Institute, Kingston, Canada.; Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Canada., Kment J; Division of Cancer Biology and Genetics, Sinclair Cancer Research Institute, Kingston, Canada.; Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Canada., Alotaibi F; Division of Cancer Biology and Genetics, Sinclair Cancer Research Institute, Kingston, Canada.; Department of Pathology and Molecular Medicine, Queen's University, Kingston, Canada.; King Saud bin Abdulaziz University for Health Science, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia., Shapovalov I; Division of Cancer Biology and Genetics, Sinclair Cancer Research Institute, Kingston, Canada.; Department of Pathology and Molecular Medicine, Queen's University, Kingston, Canada., Hoskin V; Division of Cancer Biology and Genetics, Sinclair Cancer Research Institute, Kingston, Canada.; Department of Pathology and Molecular Medicine, Queen's University, Kingston, Canada., Gao Y; Division of Cancer Biology and Genetics, Sinclair Cancer Research Institute, Kingston, Canada., Mewburn J; Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Canada., Vlasschaert C; Department of Medicine, Queen's University, Kingston, Canada., Wang A; Department of Pathology and Molecular Medicine, Queen's University, Kingston, Canada., Simonetti J; Division of Cancer Biology and Genetics, Sinclair Cancer Research Institute, Kingston, Canada.; Department of Pathology and Molecular Medicine, Queen's University, Kingston, Canada., LeBrun D; Division of Cancer Biology and Genetics, Sinclair Cancer Research Institute, Kingston, Canada.; Department of Pathology and Molecular Medicine, Queen's University, Kingston, Canada., Tyryshkin K; Department of Pathology and Molecular Medicine, Queen's University, Kingston, Canada.; School of Computing, Queen's University, Kingston, Canada., Berman DM; Division of Cancer Biology and Genetics, Sinclair Cancer Research Institute, Kingston, Canada.; Department of Pathology and Molecular Medicine, Queen's University, Kingston, Canada., Simpson AL; Division of Cancer Biology and Genetics, Sinclair Cancer Research Institute, Kingston, Canada.; Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Canada.; Department of Medicine, Queen's University, Kingston, Canada., Graham CH; Division of Cancer Biology and Genetics, Sinclair Cancer Research Institute, Kingston, Canada.; Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Canada., Craig AW; Division of Cancer Biology and Genetics, Sinclair Cancer Research Institute, Kingston, Canada.; Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Canada., Basta S; Division of Cancer Biology and Genetics, Sinclair Cancer Research Institute, Kingston, Canada.; Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Canada., Koti M; Division of Cancer Biology and Genetics, Sinclair Cancer Research Institute, Kingston, Canada.; Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Canada., Greer PA; Division of Cancer Biology and Genetics, Sinclair Cancer Research Institute, Kingston, Canada.; Department of Pathology and Molecular Medicine, Queen's University, Kingston, Canada.; Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Canada.
Source: Cancer research [Cancer Res] 2025 Jul 15; Vol. 85 (14), pp. 2643-2658.
Publication Type: Journal Article
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1538-7445
DOI:10.1158/0008-5472.CAN-24-3686